Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial

IMPORTANCE: Azithromycin has been hypothesized to have activity against SARS-CoV-2. OBJECTIVE: To determine whether oral azithromycin in outpatients with SARS-CoV-2 infection leads to absence of self-reported COVID-19 symptoms at day 14. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA
Autori principali: Oldenburg, Catherine E., Pinsky, Benjamin A., Brogdon, Jessica, Chen, Cindi, Ruder, Kevin, Zhong, Lina, Nyatigo, Fanice, Cook, Catherine A., Hinterwirth, Armin, Lebas, Elodie, Redd, Travis, Porco, Travis C., Lietman, Thomas M., Arnold, Benjamin F., Doan, Thuy
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2021
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285753/
https://ncbi.nlm.nih.gov/pubmed/34269813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.11517
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi